Companies: 10,795·Total market cap: $144.5T

Wave Life Sciences Ltd.

Wave Life Sciences Ltd.

WVENASDAQHealthcare● Active

$5.80

+$0.07(+1.13%)

Market Cap$1.1B

P/E Ratio—

52W High$21.73

52W Low$5.02

Avg Volume4.8M

Open$5.78

Beta-1.33

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Wave Life Sciences Ltd.（WVE）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · WVE · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-1.06Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$71.8MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding168.6MShares outstanding history

Next EarningsJul 30, 2026Est.Earnings history

探索 Wave Life Sciences Ltd. 数据

分析师预测$26 · Buy

股息不分红

营收$42.7M-60.55%

盈利EPS $-1.21-72.86%

财务快照

FY 2025Revenue$42.7M▼ 60.55% YoY

202320242025

FY 2025Net Income-$204.4M▼ 110.68% YoY

202320242025

FY 2025EPS$-1.21▼ 72.86% YoY

202320242025

TTM:Revenue: $71.8MNet Income: -$183.6MEPS: $-1.06View income statement →

分析师评级与目标价

Buy25 位分析师

Strong Buy

1

Buy

23

Hold

1

Sell

0

Strong Sell

0

12-Month Price Target

$13.00Low

$5.79Current

$26.09Avg Target上涨空间 350.22%

$43.00High

合计: 25 · 买入占比: 96.0%

根据过去 3 个月内 25 位华尔街分析师，WVE 共识评级为 Buy，12 个月平均目标价 $26.09 （较现价 $5.79 上涨空间 350.22%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Wave Life Sciences Ltd.

$5.80+1.13%$1.1B #2

Amylyx Pharmaceuticals, Inc.

$12.87-4.93%$1.1B #3

Enliven Therapeutics, Inc.

$33.79-2.68%$2.1B #4

Intellia Therapeutics, Inc.

$13.48-1.14%$1.5B #5

ORIC Pharmaceuticals, Inc.

$7.55-0.07%$781.6M #6

$3.66+2.37%$1.1B

股票表现

1D-0.26%

1W+0.44%

1M-20.40%

3M-56.44%

YTD-66.38%

1Y-18.94%

5Y-21.28%

关于 Wave Life Sciences Ltd.

CEOPaul Bolno

IPO DateNov 11, 2015

Employees287

CountrySG

Websitewavelifesciences.com

Wave Life Sciences Ltd. a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is de…

Biotechnology HealthcareNASDAQSG

关于股票概览与关键数据

Wave Life Sciences Ltd.（WVE）是 Biotechnology 行业的 Healthcare 类公司，于 Nov 11, 2015 在 NASDAQ 上市。截至最近交易日，WVE 股价为 $5.79，市值约为 $1.1B。过去12个月累计回报 -18.94%，年初至今回报 -66.38%。

根据 25 位华尔街分析师，Wave Life Sciences Ltd. 股票共识评级为Buy，12个月平均目标价为 $26.09。2025 财年 Wave Life Sciences Ltd. 营收 $42.7M，净利润 -$204.4M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Wave Life Sciences Ltd.（WVE）股价为 $5.79，在 NASDAQ 上市，52周区间为 $5.02 – $21.73。

WVE 最新股价WVE quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议